ABT News and Press, Abbott Laboratories From 06/12/24

New health wearables give you more options to continuously monitor your glucose levels and understand your body. NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / More and more people, whether they're weekend warriors or people living with diabetes, are coming to understand the impact that gluc...

2024-06-12 07:45:00 ET We're almost halfway through the year, and so far, it's been a pretty solid one for equity markets. It's as good a time as any to review one's portfolio and potentially consider putting more money into stocks with the understanding that our current bull market won't l...

2024-06-11 09:45:00 ET Dividend growth stocks have long been revered by investors as powerful vehicles for compounding wealth over the long term. By consistently increasing cash payouts to shareholders, these companies provide a rising income stream that can be reinvested, and turbocharged ...

2024-06-10 13:27:45 ET More on iShares U.S. Medical Devices ETF: IHI: Despite Steady Returns At Current Prices, ETF Is Fairly Valued IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF The most crowded longs and shorts in U.S. Med-Tech...

2024-06-10 08:50:03 ET Abbott Laboratories: Why I Agree With Wall Street On This One Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario Tudor Investment's to...

Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems PR Newswire Abbott's consumer biowearable, Lingo™, is designed for general consumers who are looking to improve their overall health and wellness Libre Rio™ ...

2024-06-05 11:21:33 ET More on iShares U.S. Medical Devices ETF: IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Don't expect pandemic backlog to fuel orthopedic sales, says Needham Seeking Alpha’s Quant Rating on iShares U....

2024-06-05 07:30:00 ET Summary Recent data indicates a heightened risk of stagflation, with slowing economic growth and persistent inflation. This poses challenges for the economy and portfolios, but also presents opportunities to buy beaten-down stocks with strong pricing power a...

2024-06-04 10:51:00 ET More on the markets How Might Markets React To May 2024's Job Report This Week S&P 500 will rise to record 5,500 by the end of June - Fundstrat’s Tom Lee Nasdaq, S&P, Dow tick lower as worries on economic growth surface N...

2024-06-04 00:39:47 ET Summary Wall Street analysts have a 'strong buy' rating on ABT stock, with 12 out of 24 analysts giving it this rating in the last 90 days. We agree with such bullish sentiment. Despite some risks, ABT stock has the potential to outperform the overall ma...